Spots Global Cancer Trial Database for nivolumab at the fixed dose 40 mg
Every month we try and update this database with for nivolumab at the fixed dose 40 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL | NCT06188676 | Primary Mediast... | Cyclophosphamid... Doxorubicin Hyd... Etoposide Phosp... Prednisolone Rituximab Vincristine Sul... Filgrastim Pegfilgrastim Nivolumab 40 mg... | 18 Years - 70 Years | National Research Center for Hematology, Russia |